443
Views
15
CrossRef citations to date
0
Altmetric
Review

Fibroblast growth factor 19-targeted therapies for the treatment of metabolic disease

, MD PhD FASN (Professor) , , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Nikos Lazaridis & Emmanuel Tsochatzis. (2017) Current and future treatment options in non-alcoholic steatohepatitis (NASH). Expert Review of Gastroenterology & Hepatology 11:4, pages 357-369.
Read now
Kazuhiko Kotani, Maria-Corina Serban, Peter Penson, Giuseppe Lippi & Maciej Banach. (2016) Evidence-based assessment of lipoprotein(a) as a risk biomarker for cardiovascular diseases – Some answers and still many questions. Critical Reviews in Clinical Laboratory Sciences 53:6, pages 370-378.
Read now

Articles from other publishers (13)

Mona Mohamed Ibrahim Abdalla, Jaiprakash Mohanraj & Sushela Devi Somanath. (2023) Adiponectin as a therapeutic target for diabetic foot ulcer. World Journal of Diabetes 14:6, pages 758-782.
Crossref
Meng-Chien Willie Hsieh, Wei-Ting Wang, Chuang-Yu Lin, Yur-Ren Kuo, Su-Shin Lee, Ming-Feng Hou & Yi-Chia Wu. (2022) Stem Cell-Based Therapeutic Strategies in Diabetic Wound Healing. Biomedicines 10:9, pages 2085.
Crossref
Özen ÖZ GÜL & Soner CANDER. (2022) Evaluation of sitagliptin therapy on the levels of fibroblast growth factor-19 (FGF19) in patients with Type 2 diabetes. Turkish Journal of Internal Medicine 4, pages 34-40.
Crossref
Ghada Abdelrahman Mohamed, Ehab Hasan Nashaat, Hadeer Mohamed Fawzy & Ahmed Mohamed ElGhandour. (2022) Assessment of fibroblast growth factor 19 as a non-invasive serum marker for hepatocellular carcinoma. World Journal of Hepatology 14:3, pages 623-633.
Crossref
Ye Liu, Yiqiu Liu, Junyu Deng, Wei Li & Xuqiang Nie. (2021) Fibroblast Growth Factor in Diabetic Foot Ulcer: Progress and Therapeutic Prospects. Frontiers in Endocrinology 12.
Crossref
Phuc Phan, Bibhuti Ballav Saikia, Shivakumar Sonnaila, Shilpi Agrawal, Zeina Alraawi, Thallapuranam Krishnaswamy Suresh Kumar & Shilpa Iyer. (2021) The Saga of Endocrine FGFs. Cells 10:9, pages 2418.
Crossref
Yi Sun, Minxia Zhu, Hui Zhao, Xiaoqing Ni, Renan Chang, Jianyou Su, Hua Huang, Shiwei Cui, Xinlei Wang, Jin Yuan, Jie Yuan, Rong OuYang, Rongping Zhang, Wei Chen, Yunjuan Gu & Yezi Sun. (2020) Serum Fibroblast Growth Factor 19 and Total Bile Acid Concentrations Are Potential Biomarkers of Hepatocellular Carcinoma in Patients with Type 2 Diabetes Mellitus. BioMed Research International 2020, pages 1-9.
Crossref
Yaxin Lai, Haoyu Wang, Xinghai Xia, Zhaojun Wang, Chenling Fan, Hong Wang, Hongmei Zhang, Shuangning Ding, Weiping Teng & Zhongyan Shan. (2016) Serum fibroblast growth factor 19 is decreased in patients with overt hypothyroidism and subclinical hypothyroidism. Medicine 95:39, pages e5001.
Crossref
Jing Lin, Ming Lu, Wei-qing Shao, Zong-you Chen, Wen-wei Zhu, Lu Lu, Hu-liang Jia, Duan Cai, Lun-xiu Qin & Jin-hong Chen. (2016) Osteopontin Deficiency Alters Biliary Homeostasis and Protects against Gallstone Formation. Scientific Reports 6:1.
Crossref
Xueli Zhang, Xiao Zheng & Yang Yuan. (2016) Treatment of insulin resistance: straight from the gut. Drug Discovery Today 21:8, pages 1284-1290.
Crossref
Valeria Spinelli, Oscar Chávez-Talavera, Anne Tailleux & Bart Staels. (2016) Metabolic effects of bile acid sequestration. Current Opinion in Endocrinology & Diabetes and Obesity 23:2, pages 138-144.
Crossref
Javier Donate-Correa, Ernesto Martín-Núñez, Nayra Pérez Delgado, Mercedes Muros de Fuentes, Alberto Ortiz Arduan, Carmen Mora-Fernández & Juan F. Navarro González. (2016) Implications of Fibroblast growth factor/Klotho system in glucose metabolism and diabetes. Cytokine & Growth Factor Reviews 28, pages 71-77.
Crossref
Martin Wagner & Michael Trauner. (2016) Recent advances in understanding and managing cholestasis. F1000Research 5, pages 705.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.